Shares Of Ranbaxy

'Shares Of Ranbaxy' - 70 News Result(s)

  • Supreme Court Asks Lenders To Place Loan Records Of Former Ranbaxy Promoters
    Business | Press Trust of India | Thursday February 18, 2021
    The apex court on November 15, 2019 had held former Ranbaxy promoters guilty of contempt of court for violating its order asking them not to divest their shares in FHL.
    www.ndtv.com/business
  • Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Arrested In Fraud Case
    India News | Reported by Arvind Gunasekar, Edited by Deepshikha Ghosh | Friday October 11, 2019
    Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.
    www.ndtv.com
  • "Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
    India News | Edited by Shylaja Varma | Friday April 5, 2019
    The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
    www.ndtv.com
  • Top Court Orders Status Quo On Sale Of Shares Of Fortis To Malaysian Firm
    India News | Press Trust of India | Saturday December 15, 2018
    The Supreme Court on Friday ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators -- Malvinder and Shivinder Singh.
    www.ndtv.com
  • Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
    India News | Press Trust of India | Thursday September 6, 2018
    The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
    www.ndtv.com
  • Former Ranbaxy Promoters Fined: Fortis Healthcare, Religare Fall
    Business | NDTV Profit Team | Friday May 6, 2016
    Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.
    www.ndtv.com/business
  • Sun Pharma, Dr. Reddy's Lab Shares Slump on Compliance Worries
    Business | Thomson Reuters | Monday November 9, 2015
    The two drugmakers did not give any deadline for the issues to be resolved. Kotak analysts, however, estimate Sun Pharma's Halol site - a site it had owned before the Ranbaxy deal - could be cleared by the second half of 2016.
    www.ndtv.com/business
  • Sun Pharma Falls 3% on Cautious FY16 Outlook
    Business | NDTV | Monday November 2, 2015
    Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
    www.ndtv.com/business
  • Sun Pharma Rises After Settling Patent Litigation With Actavis
    Business | NDTV | Tuesday October 6, 2015
    Shares of Sun Pharma gained as much as 2 per cent on Tuesday after Ranbaxy Pharmaceuticals, a unit of India's biggest pharma company, settled a patent litigation with Actavis over the generic version of Absorica, which is used to treat acne.
    www.ndtv.com/business
  • Strides Arcolab Surges 5% on Sun Pharmaceutical Industries Deal
    Business | NDTV | Monday September 21, 2015
    Shares of Strides Arcolab surged nearly 4 per cent to Rs 1,191 at its day's high after the Bangalore-based pharma company reached a deal with Sun Pharmaceutical Industries Ltd to buy two marketing divisions of erstwhile Ranbaxy Laboratories.
    www.ndtv.com/business
  • Sun Pharma Slumps 16% on Sales Warning
    Business | Thomson Reuters | Tuesday July 21, 2015
    Analysts estimate a roughly 8-10 per cent hit to profit for the year as Sun Pharma struggles to fix manufacturing problems at one of its own key plants and those of Ranbaxy Laboratories, the troubled rival it bought last year.
    www.ndtv.com/business
  • Sun Pharma Gains 3% on Reports of Drug Price Hike
    Business | NDTV | Tuesday June 30, 2015
    Analysts say the benefits of this price hike will be visible from the second quarter of this financial year and can lead to earnings upgrade for the company. On an annualised basis price increases can boost Sun Pharma's revenues by $45 million, some estimates suggested.
    www.ndtv.com/business
  • NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment
    Business | Press Trust of India | Tuesday April 21, 2015
    Daiichi which had forayed into the Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, today sold over 21 crore shares in Sun Pharma.
    www.ndtv.com/business
  • Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
    Business | Tuesday March 24, 2015
    Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal between the companies.
    www.ndtv.com/business
  • Sun Pharma, Ranbaxy, JSPL in Focus Today
    Business | Tuesday March 24, 2015
    The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net buyers to the tune of Rs 404 crore in cash market. Trading volume declined on Monday; cash segment ...
    www.ndtv.com/business

'Shares Of Ranbaxy' - 70 News Result(s)

  • Supreme Court Asks Lenders To Place Loan Records Of Former Ranbaxy Promoters
    Business | Press Trust of India | Thursday February 18, 2021
    The apex court on November 15, 2019 had held former Ranbaxy promoters guilty of contempt of court for violating its order asking them not to divest their shares in FHL.
    www.ndtv.com/business
  • Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Arrested In Fraud Case
    India News | Reported by Arvind Gunasekar, Edited by Deepshikha Ghosh | Friday October 11, 2019
    Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.
    www.ndtv.com
  • "Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
    India News | Edited by Shylaja Varma | Friday April 5, 2019
    The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
    www.ndtv.com
  • Top Court Orders Status Quo On Sale Of Shares Of Fortis To Malaysian Firm
    India News | Press Trust of India | Saturday December 15, 2018
    The Supreme Court on Friday ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators -- Malvinder and Shivinder Singh.
    www.ndtv.com
  • Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
    India News | Press Trust of India | Thursday September 6, 2018
    The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
    www.ndtv.com
  • Former Ranbaxy Promoters Fined: Fortis Healthcare, Religare Fall
    Business | NDTV Profit Team | Friday May 6, 2016
    Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.
    www.ndtv.com/business
  • Sun Pharma, Dr. Reddy's Lab Shares Slump on Compliance Worries
    Business | Thomson Reuters | Monday November 9, 2015
    The two drugmakers did not give any deadline for the issues to be resolved. Kotak analysts, however, estimate Sun Pharma's Halol site - a site it had owned before the Ranbaxy deal - could be cleared by the second half of 2016.
    www.ndtv.com/business
  • Sun Pharma Falls 3% on Cautious FY16 Outlook
    Business | NDTV | Monday November 2, 2015
    Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
    www.ndtv.com/business
  • Sun Pharma Rises After Settling Patent Litigation With Actavis
    Business | NDTV | Tuesday October 6, 2015
    Shares of Sun Pharma gained as much as 2 per cent on Tuesday after Ranbaxy Pharmaceuticals, a unit of India's biggest pharma company, settled a patent litigation with Actavis over the generic version of Absorica, which is used to treat acne.
    www.ndtv.com/business
  • Strides Arcolab Surges 5% on Sun Pharmaceutical Industries Deal
    Business | NDTV | Monday September 21, 2015
    Shares of Strides Arcolab surged nearly 4 per cent to Rs 1,191 at its day's high after the Bangalore-based pharma company reached a deal with Sun Pharmaceutical Industries Ltd to buy two marketing divisions of erstwhile Ranbaxy Laboratories.
    www.ndtv.com/business
  • Sun Pharma Slumps 16% on Sales Warning
    Business | Thomson Reuters | Tuesday July 21, 2015
    Analysts estimate a roughly 8-10 per cent hit to profit for the year as Sun Pharma struggles to fix manufacturing problems at one of its own key plants and those of Ranbaxy Laboratories, the troubled rival it bought last year.
    www.ndtv.com/business
  • Sun Pharma Gains 3% on Reports of Drug Price Hike
    Business | NDTV | Tuesday June 30, 2015
    Analysts say the benefits of this price hike will be visible from the second quarter of this financial year and can lead to earnings upgrade for the company. On an annualised basis price increases can boost Sun Pharma's revenues by $45 million, some estimates suggested.
    www.ndtv.com/business
  • NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment
    Business | Press Trust of India | Tuesday April 21, 2015
    Daiichi which had forayed into the Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, today sold over 21 crore shares in Sun Pharma.
    www.ndtv.com/business
  • Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
    Business | Tuesday March 24, 2015
    Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal between the companies.
    www.ndtv.com/business
  • Sun Pharma, Ranbaxy, JSPL in Focus Today
    Business | Tuesday March 24, 2015
    The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net buyers to the tune of Rs 404 crore in cash market. Trading volume declined on Monday; cash segment ...
    www.ndtv.com/business
Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com